Wearable monitors: what do we really know?
TIME’s short memory on Alzheimer’s drug failures
Is 1 in 7 Odds a Breakthrough? Is it Even Promising?
Dr. Richard Lehman: Why does having abnormal glucose tests cost the USA $245bn?
Idolatry of the surrogate: Overdiagnosis in diabetes – podcast with Dr. John S. Yudkin
LDL – Lion King of Surrogate Endpoints – key cholesterol issue this week
Monday health news roundup: mostly gems, one dud
USA Today story shows lack of awareness of debate over pre-diabetes classification
Niacin news provides another example of how surrogate outcomes don’t tell whole story
Some skeptical views of NYT front page “race for cholesterol drug” story